PreviousTo All Posts

Screen your patent portfolio against one product document

Lindsey Lavee Headshot
Lindsey Lavee
Screen your patent portfolio against one product document

Many portfolios have never been read against a single competing product. Traditionally the mapping is expensive because every step of it is manual. By the time outside counsel has gathered the evidence and charted the claims, the quarter is over and the budget line has another comma in it. The reading happens rarely, one product at a time when a negotiation forces it. The rest of the time the portfolio sits unread against the market it exists to protect.

ArcPrime now takes the document you already have and does the reading. Upload a product document, a spec or a teardown or whatever landed on your desk, and ArcPrime screens the whole portfolio for assets that read on it. Every case gets screened rather than a hand picked shortlist. The screen comes back ranked, so claim chart work starts from evidence and the expensive attention goes only to the assets that earned it.

A single document rarely carries enough context to support that analysis on its own, and it doesn't have to. ArcPrime reads your uploaded evidence and its own web research together, each filling gaps in the other. A thin spec sheet gets backed by what's publicly known about the product, and a rich teardown sharpens what the web research finds. The quality of what you happen to have in hand stops deciding the quality of the answer.

The practical shift is when the question becomes affordable to ask. Screening the portfolio against a product was a project you scheduled and sometimes quietly dropped. Now it's what you do the afternoon the document arrives, whether that's a competitor's launch announcement or the spec sheet of a licensing target someone raised in pipeline review. Each screen also leaves you with something durable. A ranked view of which assets actually face the market is exactly the evidence that pruning and renewal decisions starve for.

This doesn't replace the claim chart that has to hold up in a negotiation. It decides which claim charts are worth building, and that decision is where the money was going.

Book a demo and bring a real product document. Screening your portfolio against it live is the fastest way to see what changes.

Subscribe to our newsletter

Get the latest insights on IP strategy and patent portfolio management, straight to your inbox.

Stronger Patents.
Better Coverage.
Lower Costs.

See how ArcPrime helps IP leaders continuously optimize portfolio performance with domain-specific AI.